Xingxing Yu
Xiamen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Concordance of PD-1 expression on paired peripheral and bone marrow T cells: Surrogate potential and clinical implications in DLBCL.
Journal: The International journal of biological markers
Published: August 31, 2026
Therapeutic Activation of PPARα Inhibits Transformed Follicular Lymphoma Tumorigenesis via the FOXM1 Signaling Pathway.
Journal: International journal of biological sciences
Published: April 25, 2025
Lactate acid promotes PD-1+ Tregs accumulation in the bone marrow with high tumor burden of Acute myeloid leukemia.
Journal: International immunopharmacology
Published: January 05, 2024
High-Throughput Drug Screen for Potential Combinations With Venetoclax Guides the Treatment of Transformed Follicular Lymphoma.
Journal: International journal of toxicology
Published: June 04, 2023
Loss of CD28 expression associates with severe T-cell exhaustion in acute myeloid leukemia.
Journal: Frontiers in immunology
Published: January 07, 2023
Orelabrutinib and venetoclax synergistically induce cell death in double-hit lymphoma by interfering with the crosstalk between the PI3K/AKT and p38/MAPK signaling.
Journal: Journal of cancer research and clinical oncology
Published: September 21, 2022
Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry.
Journal: Journal of hematology & oncology
Published: May 11, 2022
Donor CSF3R with the rs3917980A/G or G/G genotype is correlated with better leukemia-free survival after allogenic hematopoietic stem cell transplantation.
Journal: Genes and immunity
Published: March 08, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026